https://www.europeanpharmaceuticalreview.com/news/177879/stem-cell-transplants-may-slow-disability-progression-in-ms/
0
0
12/22/22 at 8:15am
Organization
European Pharmaceutical Review
Authors
Stem cell transplants may delay disability longer than other medications in patients with active secondary progressive multiple sclerosis.
Create an account
or login to join the discussion